Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they have signed a Memorandum of Understanding (MoU) to form a collaboration to establish a joint Next Generation Diagnostics (NGD) center to improve personalised care, better treatments and cure as well as faster development of new safe medicines in China. The signing ceremony was conducted online in the Netherlands and China.


Have any questions?

contact us